Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Pre-Clinical Evaluation of a Camsirubicin Analog Mnpr-202 in Diffuse Large B Cell Lymphoma

Julie A.S. Lammers, Hoang Mai Phuong, Charmaine Ong, Min Liu, Patrick Jaynes, Raji R. Nair, Wee Joo Chng, Chandler D. Robinson, Anand D. Jeyasekharan

Blood (2022) 140 (Supplement 1): 5998–5999.

https://doi.org/10.1182/blood-2022-168761

Published: 2022

Journal Articles

CD56 bri CD27 + CD11b +/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

Ming Ni, MD, Peng Zhao, Qian Kang, Mei Zhao, Min Liu, Fengqi Zhang, Shisi Huang, Dan Ma, PhD, Yaming Zhang, Jiangyuan Zhao, Jishi Wang, PhD

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-141881

Published: 2020

Journal Articles

Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion

Shin-Young Park, Alessandro Matte, Yookyung Jung, Jina Ryu, Wilson Babu Anand, Eun-Young Han, Min Liu, Carmine Carbone, Davide Melisi, Takashi Nagasawa, Joseph J. Locascio, Charles P. Lin, Leslie E. Silberstein, Lucia De Franceschi

Blood (2020) 135 (23): 2071–2084.

https://doi.org/10.1182/blood.2019002227

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

The Vasculopathy in the Bone Marrow Microenvironment of Humanized Sickle Cell Mice Is Reversible By Blood Transfusion

Shin-Young Park, PhD, Alessandro Mattè, BSc,PhD, Yookyung Jung, PhD, Jina Ryu, PhD, Wilson Anand, Eun Young Anna Han, B.S., Min Liu, M.S., Carmine Carbone, Davide Melisi, Takashi Nagasawa, Charles Lin, PhD, Leslie E. Silberstein, MD, Lucia De Franceschi, MD

Blood (2019) 134 (Supplement_1): 2256.

https://doi.org/10.1182/blood-2019-123532

Published: 2019

Journal Articles

Proteometabolomics of Melphalan Resistance in Multiple Myeloma

David C. Koomen, BS, Joy D. Guingab, PhD, Paula S. Oliveira, Bin Fang, PhD, Min Liu, PhD, Eric A. Welsh, PhD, Mark B. Meads, PhD, Tuan Nguyen, Laurel E. Meke, Steven A. Eschrich, PhD, Timothy J. Garrett, PhD, John M. Koomen, PhD, Kenneth H. Shain, MD PhD

Blood (2018) 132 (Supplement 1): 5619.

https://doi.org/10.1182/blood-2018-99-117747

Published: 2018

Journal Articles

Arteriolar Neovasculogenesis and Sinusoidal Collapse Are Pathologic Features of the Hematopoietic Stem Cell Niche in Sickle Cell Disease (SCD) Mice

Shin-Young Park, PhD, Alessandro Mattè, PhD, Eun Young Anna Han, B.S., Min Liu, M.S., Jina Ryu, PhD, Lucia De Franceschi, MD, Leslie E. Silberstein, MD

Blood (2017) 130 (Supplement 1): 3522.

https://doi.org/10.1182/blood.V130.Suppl_1.3522.3522

Published: 2017

Journal Articles

Uncovering the mystery of opposite circadian rhythms between mouse and human leukocytes in humanized mice

Yue Zhao, Min Liu, Xue Ying Chan, Sue Yee Tan, Sharrada Subramaniam, Yong Fan, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Qingfeng Chen

Blood (2017) 130 (18): 1995–2005.

https://doi.org/10.1182/blood-2017-04-778779

Published: 2017

Includes: Supplemental data

Journal Articles

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Libing Wang, Xiaoxia Hu, Lei Gao, Sheng Xu, Shenglan Gong, Li Chen, Shuqing Lü, Jie Chen, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Xianmin Song, Weiping Zhang, Jianmin Yang, Min Liu, Jianmin Wang, MD

Blood (2013) 122 (21): 1379.

https://doi.org/10.1182/blood.V122.21.1379.1379

Published: 2013

Journal Articles

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Xiaoxia Hu, Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Min Liu, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Li Chen, Shuqing Lü, Jie Chen, Xianmin Song, Weiping Zhang, Jianmin Yang, Jianmin Wang, MD

Blood (2013) 122 (21): 1356.

https://doi.org/10.1182/blood.V122.21.1356.1356

Published: 2013

Journal Articles

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Blood (2013) 121 (20): 4021–4031.

https://doi.org/10.1182/blood-2012-10-460063

Published: 2013

Includes: Supplemental data

Journal Articles

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Blood (2013) 121 (14): 2715–2724.

https://doi.org/10.1182/blood-2012-10-461848

Published: 2013

Includes: Supplemental data

Journal Articles

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Blood (2012) 120 (19): 3986–3996.

https://doi.org/10.1182/blood-2012-05-433334

Published: 2012

Includes: Supplemental data

Journal Articles

Regulatory-Approval Driven Safety and Efficacy of MGMTP140K Lentivirus Transduction of Human CD34+ Cells for a Phase I Clinical Trial for Upfront Treatment of Glioma,

Yulan Qing, PhD, Jane Reese, Min Liu, Amar Desai, Heather Embree, Boro Dropulic, MBA, PhD, Stanton L. Gerson, MD

Blood (2011) 118 (21): 4177.

https://doi.org/10.1182/blood.V118.21.4177.4177

Published: 2011

Journal Articles

CYLD regulates angiogenesis by mediating vascular endothelial cell migration

Jinmin Gao, Lei Sun, Lihong Huo, Min Liu, Dengwen Li, Jun Zhou

Blood (2010) 115 (20): 4130–4137.

https://doi.org/10.1182/blood-2009-10-248526

Published: 2010

Includes: Supplemental data

Journal Articles

Exo1 Independent DNA Mismatch Repair Pathway in Hematopoiesis.

Amar Desai, Yulan Qing, PhD, Min Liu, Jonathan Kenyon, BS, Uchenna Nwafor, Stanton L. Gerson, MD

Blood (2009) 114 (22): 2526.

https://doi.org/10.1182/blood.V114.22.2526.2526

Published: 2009

Journal Articles

Regulation of Hematopoietic Stem Cell Quiescence by Ku70.

Yulan Qing, PhD, Zhengqi Wang, Ph.D., Min Liu, Kevin D. Bunting, PhD, Stanton L. Gerson, MD

Blood (2009) 114 (22): 3613.

https://doi.org/10.1182/blood.V114.22.3613.3613

Published: 2009

Journal Articles

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

Ken I. Mills, Alexander Kohlmann, P. Mickey Williams, Lothar Wieczorek, Wei-min Liu, Rachel Li, Wen Wei, David T. Bowen, Helmut Loeffler, Jesus M. Hernandez, Wolf-Karsten Hofmann, Torsten Haferlach

Blood (2009) 114 (5): 1063–1072.

https://doi.org/10.1182/blood-2008-10-187203

Published: 2009

Includes: Supplemental data

Journal Articles

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Blood (2008) 112 (11): 753.

https://doi.org/10.1182/blood.V112.11.753.753

Published: 2008

Journal Articles

Intraplatform Reproducibility and Technical Precision of Gene Expression Profiling in Four Laboratories Investigating 112 Leukemia Samples: The DACH Study.

Alexander Kohlmann, PhD, Elisabeth Haschke-Becher, MD, Barbara Wimmer, PhD, Ariana Huber-Wechselberger, PhD, Sandrine Meyer-Monard, MD, Heike Huxol, Uwe Siegler, PhD, Michel Rossier, PhD, Thomas Matthes, MD, Michela Rebsamen, PhD, Adeline Diemand, Alberto Chiappe, Sonja Rauhut, Wei-min Liu, PhD, Andrea Johnson, PhD, Lothar Wieczorek, PhD, Torsten Haferlach, MD

Blood (2007) 110 (11): 2383.

https://doi.org/10.1182/blood.V110.11.2383.2383

Published: 2007

Journal Articles

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

Ken I. Mills, PhD, Alex Kohlmann, Ph.D., Mickey Williams, Ph.D., Wei-Min Liu, Ph.D., Rachel Li, David T. Bowen, M.D., Helmut Loeffler, M.D., Jesus M. Hernandez, M.D., Wolf-Karsten Hofmann, M.D., Torsten Haferlach, M.D., Lothar Wieczirek, Ph.D.

Blood (2007) 110 (11): 2426.

https://doi.org/10.1182/blood.V110.11.2426.2426

Published: 2007

NARROW

Pre-Clinical Evaluation of a Camsirubicin Analog Mnpr-202 in Diffuse Large B Cell Lymphoma

CD56 bri CD27 + CD11b +/- NK Cells Mediated Remission of Agvhd Via Immunoregulation

Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion

The Vasculopathy in the Bone Marrow Microenvironment of Humanized Sickle Cell Mice Is Reversible By Blood Transfusion

Proteometabolomics of Melphalan Resistance in Multiple Myeloma

Arteriolar Neovasculogenesis and Sinusoidal Collapse Are Pathologic Features of the Hematopoietic Stem Cell Niche in Sickle Cell Disease (SCD) Mice

Uncovering the mystery of opposite circadian rhythms between mouse and human leukocytes in humanized mice

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Regulatory-Approval Driven Safety and Efficacy of MGMTP140K Lentivirus Transduction of Human CD34+ Cells for a Phase I Clinical Trial for Upfront Treatment of Glioma,

CYLD regulates angiogenesis by mediating vascular endothelial cell migration

Exo1 Independent DNA Mismatch Repair Pathway in Hematopoiesis.

Regulation of Hematopoietic Stem Cell Quiescence by Ku70.

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Intraplatform Reproducibility and Technical Precision of Gene Expression Profiling in Four Laboratories Investigating 112 Leukemia Samples: The DACH Study.

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only